Insurance and Benefit Design: Government provides insights on potential changes in government plan benefits over the next two years, assisting companies in anticipating emerging access opportunities and risks.
How are market trends and government policies transforming the Part B market, and how will access evolve as a result?
How are market trends and government policies changing the Part D market, and how will access evolve as a result?
What drug control activities are states pursuing, and what actions should biopharmaceutical companies take to appropriately prepare across states?
What actions should companies take to appropriately respond to the changing underinsured landscape, including Medicaid, health insurance exchanges and potential new coverage options?
Use Insurance and Benefit Design: Government to:
- Develop effective business strategies for the evolving Medicare Part B landscape
- Develop effective business strategies for the evolving Medicare Part D landscape
- Gain deeper understanding of state efforts to regulate healthcare business practices including drug pricing, importation, and contract negotiations
- Monitor changes to Medicaid and exchange marketplace landscapes and assess their impact on patient access
-
Part B Management Trends March
- Assessment of Part B market movement
- Trends in Part B benefit design and cost sharing
- Assessment of proposed policy changes under Part B
- Impact of Part B regulations on stakeholders
-
Part D Management Trends July
- Trends in Part D benefit design and cost sharing
- Comparison of MA-PD and PDP business models
- Assessment of proposed policy changes under Part D
- Impact of Part D regulations on stakeholders
-
State Pharmacy Control Dynamics August
- Assessment of state pharmacy control activities and their impact on access
-
Medicaid and Underinsured Trends November
- Overview of recent Medicaid rule changes that affect access
- State utilization of 1115 waivers
- Availability of additional coverage options
- Exchange marketplace shifts
-
Market Alerts
Timely analysis of payer reactions to significant recent events, including:
- Congressional activity relating to government programs
- CMS policy releases
- Medicare/Medicaid/exchange plan business activities